Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of weekly Invicorp injections for erectile dysfunction after radical prostatectomy
ISRCTN77251669Phase 4Completed
- Sponsor
- RestoriT
- Start
- Aug 2022
- Modality
- Small Molecules, Peptides
01
Overview
Phase 4, open-label, single-arm trial of aviptadil in erectile dysfunction (ED), sponsored by RestoriT. Primary endpoint: International Index of Erectile Function (IIEF-15). Started Aug 2022; status: completed.
02
Drugs
aviptadil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ISRCTN77251669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN77251669.